Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WorldHeart buys another ventricular assist device

This article was originally published in Clinica

Executive Summary

WorldHeart, the Oakland, California firm that makes the Novacor LVAS (left ventricular assist system), has acquired another ventricular assist device (VAD) through the purchase of Salt Lake City, Utah-based MedQuest Products. MedQuest's HeartQuest device is a magnetically levitated centrifugal rotary blood pump, while Novacor is a pulsatile device. WorldHeart says pulsatile systems are best suited for end-stage patients with poor ventricular contractility requiring full support, while rotary devices are better for late-stage patients requiring only partial support.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts